ArticleNoro psikiyatri arsivi2025
Oxidative Stress and Thiol-disulphide Hemostasis in Children with Anxiety Disorders.
Article in Noro psikiyatri arsivi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anxiety disorders (AD) constitute a significant part of mental health problems; however, their pathogenesis remains not fully elucidated. The balance between the oxidative and antioxidative systems are disrupted in children with AD. The total oxidant/antioxidant status (TOS/TAS) and thiol/disulphide homeostasis (TDH) show oxidative stress through different mechanisms. To date, research in this context has tended to focus on adults rather than children. Despite this, understanding oxidative stress in pediatric populations is increasingly emphasized. Therefore, this research aims to investigate TOS/TAS and TDH in children with AD. Methods: The study included 40 treatment-naive children with AD and 40 healthy controls matched by age and sex. Sociodemographic data and The Screen for Child Anxiety-Related Emotional Disorders (SCARED) were used for assessment. Results: The results showed that TOS and the Oxidative Stress Index (OSI) were elevated, and TAS was reduced in children with AD compared to controls. However, when evaluated in terms of TDH, there was no significant difference. Logistic regression analysis identified TOS as a significant predictor of AD (p=0.027; OR=5.49, 95% CI: 1.21-24.84). Although dynamic-disulphide level improved the model's predictive accuracy, they did not reach statistical significance (p=0.063). Conclusion: These findings suggest a potential oxidative dysfunction in AD. The study highlights the potential utility of TOS as a robust biomarker for distinguishing pediatric AD from HC. Furthermore, the absence of significant changes in TDH suggests that oxidative stress in pediatric AD may primarily involve alternative pathways. This may involve a complex interplay of DNA damage, lipid peroxidation, and protein oxidation processes contributing to the oxidative stress observed in AD. To explore the potential for using oxidative stress markers as novel targets for treatment and diagnostic tools for AD, prospective, large-scale, randomized trials are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.